|
1
|
Candore G, Accardi G, Aiello A, Baggio G, Bellini T, Calabrese V, Carreca AP, Carreca I, Masucci A, Cattaneo M, Dato S, Bona DD, Fabris L, Gambino C, Lorenzo GD, Franceschi C, Ligotti ME, Manfrinato MC, Puca AA, Tamburello M, Vassallo R, Caruso C. Sex and Gender in Ageing and Longevity: Highlights From an International Course. Transl Med UniSa 2024; 26:15-29. [PMID: 38560614 PMCID: PMC10980291 DOI: 10.37825/2239-9747.1049] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2023] [Accepted: 02/03/2024] [Indexed: 04/04/2024] Open
Abstract
Gender medicine is a multidisciplinary science and represents an important perspective for pathophysiological and clinical studies in the third millennium. Here, it is provided an overview of the topics discussed in a recent course on the Role of Sex and Gender in Ageing and Longevity. The paper highlights three themes discussed in the course, i.e., the interaction of gender/sex with, i) the pathophysiology of age-related diseases; ii), the role of genetics and epigenetics in ageing and longevity and, iii) the immune responses of older people to pathogens, vaccines, autoantigens, and allergens. Although largely unexplored, it is clear that sex and gender are modulators of disease biology and treatment outcomes. It is becoming evident that men and women should no longer be considered as subgroups, but as biologically distinct groups of patients deserving consideration for specific therapeutic approaches.
Collapse
Affiliation(s)
- Giuseppina Candore
- Laboratory of Immunopathology and Immunosenescence, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo,
Italy
- Department of Laboratory Medicine, University Hospital “P.Giaccone”, Palermo,
Italy
| | - Giulia Accardi
- Laboratory of Immunopathology and Immunosenescence, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo,
Italy
| | - Anna Aiello
- Laboratory of Immunopathology and Immunosenescence, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo,
Italy
| | - Giovannella Baggio
- Italian Center for Studies on Gender Health and Medicine, Padua University-Hospital, Padua,
Italy
| | - Tiziana Bellini
- University Center for Studies on Gender Medicine, University of Ferrara, Ferrara,
Italy
- Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara,
Italy
| | - Vittorio Calabrese
- Department of Biomedical and Biotechnological Sciences, University of Catania,
Italy
| | | | - Ignazio Carreca
- Section of Medical Oncology, Department of Surgical, Oncological and Oral Sciences, University of Palermo, Palermo,
Italy
| | - Anna Masucci
- Department of Laboratory Medicine, University Hospital “P.Giaccone”, Palermo,
Italy
- Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo,
Italy
| | | | - Serena Dato
- Department of Biology, Ecology and Earth Sciences, University of Calabria, Rende,
Italy
| | - Danilo D. Bona
- Department of Medical and Surgical Sciences, University of Foggia, Foggia,
Italy
| | - Luca Fabris
- Italian Center for Studies on Gender Health and Medicine, Padua University-Hospital, Padua,
Italy
- Department of Medicine, University of Padua, Padua,
Italy
- Department of Internal Medicine, Digestive Disease Section, Yale University, New Haven, CT,
USA
| | - Caterina Gambino
- Department of Laboratory Medicine, University Hospital “P.Giaccone”, Palermo,
Italy
- Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo,
Italy
| | - Gabriele D. Lorenzo
- Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo,
Italy
| | - Claudio Franceschi
- Institute of Information Technologies, Mathematics and Mechanics, Lobachevsky State University, Nizhny Novgorod,
Russia
- Institute of Biogerontology, Lobachevsky State University, Nizhny Novgorod,
Russia
| | - Mattia E. Ligotti
- Department of Research, ISMETT-IRCCS Mediterranean Institute for Transplants and Highly Specialized Therapies, Palermo,
Italy
| | - Maria C. Manfrinato
- University Center for Studies on Gender Medicine, University of Ferrara, Ferrara,
Italy
- Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara,
Italy
| | - Annibale A. Puca
- Cardiovascular Department, IRCCS MultiMedica, Milan,
Italy
- Department of Medicine, Surgery and Dentistry, University of Salerno, Salerno,
Italy
| | - Martina Tamburello
- Department of Laboratory Medicine, University Hospital “P.Giaccone”, Palermo,
Italy
- Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo,
Italy
| | - Roberta Vassallo
- Department of Laboratory Medicine, University Hospital “P.Giaccone”, Palermo,
Italy
- Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo,
Italy
| | - Calogero Caruso
- Laboratory of Immunopathology and Immunosenescence, Department of Biomedicine, Neurosciences and Advanced Diagnostics, University of Palermo, Palermo,
Italy
| |
Collapse
|
|
2
|
Li J, Yin Y, Huang H, Li M, Li H, Zhang M, Jiang C, Yang R. RUNX1 methylation as a cancer biomarker in differentiating papillary thyroid cancer from benign thyroid nodules. Epigenomics 2023; 15:1257-1272. [PMID: 38126720 DOI: 10.2217/epi-2023-0338] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2023] Open
Abstract
Aim: It remains a challenge to accurately identify malignancy of thyroid nodules when biopsy is indeterminate. The authors aimed to investigate the abnormal DNA methylation signatures in papillary thyroid cancer (PTC) compared with benign thyroid nodules (BTNs). Methods: The authors performed genome profiling by 850K array and RNA sequencing in early-stage PTC and BTN tissue samples. The identified gene was validated in two independent case-control studies using mass spectrometry. Results: Hypomethylation of RUNX1 in PTC was identified and verified (all odds ratios: ≥1.50). RUNX1 methylation achieved good accuracy in differentiating early-stage PTC from BTNs, especially for younger women. Conclusion: The authors disclosed a significant association between RUNX1 hypomethylation and PTC, suggesting RUNX1 methylation as a potential biomarker for companion diagnosis of malignant thyroid nodules.
Collapse
Affiliation(s)
- Junjie Li
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, 210000, China
| | - Yifei Yin
- Department of Thyroid & Breast Surgery, Affiliated Huai'an Hospital of Xuzhou Medical University & Second People's Hospital of Huai'an, Huai'an, 223000, China
| | - Haixia Huang
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, 210000, China
| | - Mengxia Li
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, 210000, China
| | - Hong Li
- Department of Pathology, Affiliated Huai'an Hospital of Xuzhou Medical University & Second People's Hospital of Huai'an, Huai'an, 223000, China
| | - Minmin Zhang
- Department of Thyroid & Breast Surgery, Affiliated Huai'an Hospital of Xuzhou Medical University & Second People's Hospital of Huai'an, Huai'an, 223000, China
| | - Chenxia Jiang
- Department of Pathology, Affiliated Hospital of Nantong University, Nantong, 226001, China
| | - Rongxi Yang
- Department of Epidemiology, School of Public Health, Nanjing Medical University, Nanjing, 210000, China
| |
Collapse
|